TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs10945919
log Bayes Factor = <0.0001
Chromosome 6   position 164,186,677  (GRCh37) Explore rs10945919 on Ensembl!
Variant rs10945919 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
T46 Poisoning by agents primarily affecting the cardiovascular system
0.089 0.911 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.085 0.915 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.084 0.916 0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.083 0.917 0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.081 0.919 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.075 0.925 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.074 0.926 0.000
T36 Poisoning by systemic antibiotics
0.074 0.926 0.000
T40.4 Other synthetic narcotics
0.071 0.929 0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.070 0.930 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.070 0.930 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.069 0.931 0.000
T46.1 Calcium-channel blockers
0.069 0.931 0.000
T46.5 Other antihypertensive drugs, not elsewhere classified
0.068 0.931 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.066 0.933 0.000
T36.0 Penicillins
0.066 0.934 0.000
T40.3 Methadone
0.065 0.934 0.000
T40.2 Other opioids
0.065 0.935 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.065 0.935 0.000
T40.6 Other and unspecified narcotics
0.065 0.935 0.000
T43.5 Other and unspecified antipsychotics and neuroleptics
0.065 0.935 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.065 0.935 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.064 0.936 0.000
T46.7 Peripheral vasodilators
0.064 0.936 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.064 0.936 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.064 0.936 0.000
T43.2 Other and unspecified antidepressants
0.063 0.937 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.062 0.938 0.000
T47.1 Other antacids and anti-gastric-secretion drugs
0.062 0.938 0.000
T47.0 Histamine H(2)-receptor antagonists
0.061 0.939 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.060 0.939 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.060 0.939 0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.059 0.941 0.000
T40.5 Cocaine
0.059 0.941 0.000
T37.8 Other specified systemic anti-infectives and antiparasitics
0.058 0.941 0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.058 0.942 0.000
T40.8 Lysergide [LSD]
0.058 0.942 0.000
T40.7 Cannabis (derivatives)
0.058 0.942 0.000
T40.1 Heroin
0.058 0.942 0.000
T40.0 Opium
0.058 0.942 0.000
T43.9 Psychotropic drug, unspecified
0.054 0.946 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.054 0.946 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.054 0.946 0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.054 0.946 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.053 0.946 0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.053 0.947 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.053 0.947 0.000
T47.7 Emetics
0.053 0.947 0.000
T47.6 Antidiarrhoeal drugs
0.053 0.947 0.000
T47.5 Digestants
0.053 0.947 0.000
T47.4 Other laxatives
0.053 0.947 0.000
T47.3 Saline and osmotic laxatives
0.053 0.947 0.000
T47.2 Stimulant laxatives
0.053 0.947 0.000
T36.9 Systemic antibiotic, unspecified
0.053 0.947 0.000
T36.8 Other systemic antibiotics
0.053 0.947 0.000
T36.7 Antifungal antibiotics, systemically used
0.053 0.947 0.000
T36.6 Rifamycins
0.053 0.947 0.000
T36.5 Aminoglycosides
0.053 0.947 0.000
T36.4 Tetracyclines
0.053 0.947 0.000
T36.3 Macrolides
0.053 0.947 0.000
T36.2 Chloramphenicol group
0.053 0.947 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.053 0.947 0.000
T43.6 Psychostimulants with abuse potential
0.053 0.947 0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.051 0.949 0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.050 0.949 0.000
T37.5 Antiviral drugs
0.050 0.949 0.000
T37.4 Anthelminthics
0.050 0.949 0.000
T37.3 Other antiprotozoal drugs
0.050 0.949 0.000
T37.1 Antimycobacterial drugs
0.050 0.949 0.000
T37.0 Sulphonamides
0.050 0.949 0.000
T45.2 Vitamins, not elsewhere classified
0.050 0.950 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.048 0.952 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.048 0.952 0.000
T49.9 Topical agent, unspecified
0.047 0.953 0.000
T49.8 Other topical agents
0.047 0.953 0.000
T49.7 Dental drugs, topically applied
0.047 0.953 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.047 0.953 0.000
T49.5 Ophthalmological drugs and preparations
0.047 0.953 0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.047 0.953 0.000
T49.3 Emollients, demulcents and protectants
0.047 0.953 0.000
T49.2 Local astringents and local detergents
0.047 0.953 0.000
T49.1 Antipruritics
0.047 0.953 0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.047 0.953 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.047 0.953 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.047 0.953 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.047 0.953 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.047 0.953 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.047 0.953 0.000
T44.0 Anticholinesterase agents
0.047 0.953 0.000
T45.0 Antiallergic and antiemetic drugs
0.046 0.953 0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.046 0.954 0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.046 0.954 0.000
T45.5 Anticoagulants
0.045 0.955 0.000
T45.9 Primarily systemic and haematological agent, unspecified
0.045 0.955 0.000
T45.8 Other primarily systemic and haematological agents
0.045 0.955 0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.045 0.955 0.000
T45.6 Fibrinolysis-affecting drugs
0.045 0.955 0.000
T45.4 Iron and its compounds
0.045 0.955 0.000
T45.3 Enzymes, not elsewhere classified
0.045 0.955 0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.045 0.955 0.000
T41.5 Therapeutic gases
0.043 0.956 0.000
T41.4 Anaesthetic, unspecified
0.043 0.956 0.000
T41.3 Local anaesthetics
0.043 0.956 0.000
T41.2 Other and unspecified general anaesthetics
0.043 0.956 0.000
T41.1 Intravenous anaesthetics
0.043 0.956 0.000
T41.0 Inhaled anaesthetics
0.043 0.956 0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.043 0.956 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.043 0.956 0.000
T48.5 Anti-common-cold drugs
0.043 0.956 0.000
T48.4 Expectorants
0.043 0.956 0.000
T48.3 Antitussives
0.043 0.956 0.000
T48.2 Other and unspecified agents primarily acting on muscles
0.043 0.956 0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.043 0.956 0.000
T48.0 Oxytocic drugs
0.043 0.956 0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.043 0.957 0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.043 0.957 0.000
T42.5 Mixed antiepileptics, not elsewhere classified
0.042 0.957 0.000
T42.3 Barbiturates
0.042 0.957 0.000
T42.2 Succinimides and oxazolidinediones
0.042 0.957 0.000
T42.1 Iminostilbenes
0.042 0.957 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.040 0.960 0.000
T42.4 Benzodiazepines
0.040 0.960 0.000
T45.1 Antineoplastic and immunosuppressive drugs
0.038 0.961 0.000
T43.0 Tricyclic and tetracyclic antidepressants
0.037 0.963 0.000
T42.0 Hydantoin derivatives
0.036 0.963 0.000
T38.9 Other and unspecified hormone antagonists
0.034 0.965 0.000
T38.7 Androgens and anabolic congeners
0.034 0.965 0.000
T38.5 Other oestrogens and progestogens
0.034 0.965 0.000
T38.4 Oral contraceptives
0.034 0.965 0.000
T38.2 Antithyroid drugs
0.034 0.965 0.000
T38.0 Glucocorticoids and synthetic analogues
0.034 0.965 0.000
T38.1 Thyroid hormones and substitutes
0.034 0.966 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.034 0.966 0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.032 0.968 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.031 0.969 0.000
T50.4 Drugs affecting uric acid metabolism
0.030 0.970 0.000
T50.7 Analeptics and opioid receptor antagonists
0.029 0.971 0.000
T50.5 Appetite depressants
0.029 0.971 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.029 0.971 0.000
T50.1 Loop [high-ceiling] diuretics
0.029 0.971 0.000
T50.0 Mineralocorticoids and their antagonists
0.029 0.971 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.028 0.972 0.000
T50.8 Diagnostic agents
0.027 0.972 0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.027 0.973 0.000
Z98.8 Other specified postsurgical states
0.000 0.984 0.016
E85.4 Organ-limited amyloidosis
0.014 0.986 0.000
E85 Amyloidosis
0.014 0.986 0.000
E85.9 Amyloidosis, unspecified
0.013 0.987 0.000
S68.1 Traumatic amputation of other single finger (complete)(partial)
0.000 0.987 0.013
R07.2 Precordial pain
0.000 0.987 0.013
E85.3 Secondary systemic amyloidosis
0.013 0.987 0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.013 0.987 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.011 0.989 0.000
C83 Diffuse non-Hodgkin's lymphoma
0.011 0.989 0.000
E85.8 Other amyloidosis
0.011 0.989 0.000
C83.0 Small cell (diffuse)
0.011 0.989 0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.010 0.990 0.000
E85.2 Heredofamilial amyloidosis, unspecified
0.010 0.990 0.000
E85.1 Neuropathic heredofamilial amyloidosis
0.010 0.990 0.000
E85.0 Nonneuropathic heredofamilial amyloidosis
0.010 0.990 0.000
C83.1 Small cleaved cell (diffuse)
0.010 0.990 0.000
E04.9 Non-toxic goitre, unspecified
0.000 0.990 0.010
I71.9 Aortic aneurysm of unspecified site, without mention of rupture
0.010 0.990 0.000
T39.4 Antirheumatics, not elsewhere classified
0.009 0.991 0.000
T39.2 Pyrazolone derivatives
0.009 0.991 0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.009 0.991 0.000
C83.3 Large cell (diffuse)
0.009 0.991 0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.009 0.991 0.000
C91 Lymphoid leukaemia
0.009 0.991 0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.009 0.991 0.000
C91.5 Adult T-cell leukaemia
0.008 0.992 0.000
C83.6 Undifferentiated (diffuse)
0.008 0.992 0.000
C83.5 Lymphoblastic (diffuse)
0.008 0.992 0.000
C83.4 Immunoblastic (diffuse)
0.008 0.992 0.000
C83.2 Mixed small and large cell (diffuse)
0.008 0.992 0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.008 0.992 0.000
C91.0 Acute lymphoblastic leukaemia
0.008 0.992 0.000
C88 Malignant immunoproliferative diseases
0.008 0.992 0.000
C95 Leukaemia of unspecified cell type
0.008 0.992 0.000
C83.7 Burkitt's tumour
0.008 0.992 0.000
C88.0 Waldenstrom's macroglobulinaemia
0.007 0.993 0.000
C95.1 Chronic leukaemia of unspecified cell type
0.007 0.993 0.000
E05.9 Thyrotoxicosis, unspecified
0.007 0.993 0.000
C92 Myeloid leukaemia
0.007 0.993 0.000
N42.1 Congestion and haemorrhage of prostate
0.000 0.993 0.007
C95.9 Leukaemia, unspecified
0.007 0.993 0.000
C93 Monocytic leukaemia
0.007 0.993 0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.006 0.993 0.000
C91.8 Mature B-cell leukaemia Burkitt-type
0.006 0.993 0.000
C91.7 Other lymphoid leukaemia
0.006 0.993 0.000
C91.6 Prolymphocytic leukaemia of T-cell type
0.006 0.993 0.000
C91.3 Prolymphocytic leukaemia
0.006 0.993 0.000
C91.2 Subacute lymphocytic leukaemia
0.006 0.993 0.000
Z90.0 Acquired absence of part of head and neck
0.007 0.993 0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.006 0.993 0.000
C94 Other leukaemias of specified cell type
0.006 0.993 0.000
C86 Other specified types of T/NK-cell lymphoma
0.006 0.993 0.000
T39.0 Salicylates
0.006 0.994 0.000
C81 Hodgkin's disease
0.006 0.994 0.000
C91.4 Hairy-cell leukaemia
0.006 0.994 0.000
C91.1 Chronic lymphocytic leukaemia
0.006 0.994 0.000
C91.9 Lymphoid leukaemia, unspecified
0.006 0.994 0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.006 0.994 0.000
C88.9 Malignant immunoproliferative disease, unspecified
0.006 0.994 0.000
C88.7 Other malignant immunoproliferative diseases
0.006 0.994 0.000
C88.3 Immunoproliferative small intestinal disease
0.006 0.994 0.000
C88.2 Gamma heavy chain disease
0.006 0.994 0.000
C88.1 Alpha heavy chain disease
0.006 0.994 0.000
C95.7 Other leukaemia of unspecified cell type
0.006 0.994 0.000
C95.2 Subacute leukaemia of unspecified cell type
0.006 0.994 0.000
C95.0 Acute leukaemia of unspecified cell type
0.006 0.994 0.000
C92.1 Chronic myeloid leukaemia
0.006 0.994 0.000
E05.0 Thyrotoxicosis with diffuse goitre
0.006 0.994 0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.006 0.994 0.000
E05 Thyrotoxicosis [hyperthyroidism]
0.006 0.994 0.000
C81.7 Other Hodgkin's disease
0.006 0.994 0.000
C92.2 Subacute myeloid leukaemia
0.006 0.994 0.000
R04.2 Haemoptysis
0.006 0.994 0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.005 0.995 0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.005 0.995 0.000
C92.5 Acute myelomonocytic leukaemia
0.005 0.995 0.000
C92.3 Myeloid sarcoma
0.005 0.995 0.000
C84 Peripheral and cutaneous T-cell lymphomas
0.005 0.995 0.000
C92.9 Myeloid leukaemia, unspecified
0.005 0.995 0.000
C93.1 Chronic monocytic leukaemia
0.005 0.995 0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.005 0.995 0.000
C92.7 Other myeloid leukaemia
0.005 0.995 0.000
K80.5 Calculus of bile duct without cholangitis or cholecystitis
0.005 0.995 0.000
C93.9 Monocytic leukaemia, unspecified
0.005 0.995 0.000
C93.7 Other monocytic leukaemia
0.005 0.995 0.000
C93.3 Juvenile myelomonocytic leukaemia
0.005 0.995 0.000
C93.2 Subacute monocytic leukaemia
0.005 0.995 0.000
C93.0 Acute monocytic leukaemia
0.005 0.995 0.000
C92.0 Acute myeloid leukaemia
0.005 0.995 0.000
E04 Other non-toxic goitre
0.000 0.995 0.005
C92.4 Acute promyelocytic leukaemia
0.005 0.995 0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.005 0.995 0.000
C86.5 Angioimmunoblastic T-cell lymphoma
0.005 0.995 0.000
C86.4 Blastic NK-cell lymphoma
0.005 0.995 0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.005 0.995 0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.005 0.995 0.000
C86.1 Hepatosplenic T-cell lymphoma
0.005 0.995 0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.005 0.995 0.000
C94.7 Other specified leukaemias
0.005 0.995 0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.005 0.995 0.000
C94.5 Acute myelofibrosis
0.005 0.995 0.000
C94.4 Acute panmyelosis
0.005 0.995 0.000
C94.3 Mast cell leukaemia
0.005 0.995 0.000
C94.2 Acute megakaryoblastic leukaemia
0.005 0.995 0.000
C94.1 Chronic erythraemia
0.005 0.995 0.000
C94.0 Acute erythraemia and erythroleukaemia
0.005 0.995 0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.005 0.995 0.000
C96.8 Histiocytic sarcoma
0.005 0.995 0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.005 0.995 0.000
C96.6 Unifocal Langerhans-cell histiocytosis
0.005 0.995 0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.005 0.995 0.000
C96.4 Sarcoma of dendritic cells (accessory cells)
0.005 0.995 0.000
C96.3 True histiocytic lymphoma
0.005 0.995 0.000
C96.2 Malignant mast cell tumour
0.005 0.995 0.000
C96.1 Malignant histiocytosis
0.005 0.995 0.000
C96.0 Letterer-Siwe disease
0.005 0.995 0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.005 0.995 0.000
C81.0 Lymphocytic predominance
0.005 0.995 0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.005 0.995 0.000
C81.3 Lymphocytic depletion
0.005 0.995 0.000
C85.0 Lymphosarcoma
0.005 0.995 0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.005 0.995 0.000
E04.0 Non-toxic diffuse goitre
0.000 0.995 0.005
C81.2 Mixed cellularity
0.005 0.995 0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.004 0.996 0.000
E05.5 Thyroid crisis or storm
0.004 0.996 0.000
E05.4 Thyrotoxicosis factitia
0.004 0.996 0.000
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.004 0.996 0.000
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.004 0.996 0.000
C81.1 Nodular sclerosis
0.004 0.996 0.000
M06.94 Rheumatoid arthritis, unspecified (Hand)
0.000 0.996 0.004
C84.9 Mature T/NK-cell lymphoma, unspecified
0.004 0.996 0.000
C84.8 Cutaneous T-cell lymphoma, unspecified
0.004 0.996 0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.004 0.996 0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.004 0.996 0.000
C84.3 Lymphoepithelioid lymphoma
0.004 0.996 0.000
C84.2 T-zone lymphoma
0.004 0.996 0.000
C84.1 Sezary's diease
0.004 0.996 0.000
M51.2 Other specified intervertebral disk displacement
0.004 0.996 0.000
C84.4 Peripheral T-cell lymphoma
0.004 0.996 0.000
T39.1 4-Aminophenol derivatives
0.004 0.996 0.000
C81.9 Hodgkin's disease, unspecified
0.004 0.996 0.000
E05.8 Other thyrotoxicosis
0.004 0.996 0.000
C84.0 Mycosis fungoides
0.004 0.996 0.000
C85.7 Other specified types of non-Hodgkin's lymphoma
0.004 0.996 0.000
E04.8 Other specified non-toxic goitre
0.000 0.996 0.004
Z98 Other postsurgical states
0.000 0.996 0.004
D89.2 Hypergammaglobulinaemia, unspecified
0.004 0.996 0.000
H65.3 Chronic mucoid otitis media
0.000 0.996 0.004
C82.3 Follicular lymphoma grade IIIa
0.004 0.996 0.000
E04.2 Non-toxic multinodular goitre
0.000 0.996 0.004
C82.6 Cutaneous follicle centre lymphoma
0.004 0.996 0.000
C82.5 Diffuse follicle centre lymphoma
0.004 0.996 0.000
C82.4 Follicular lymphoma grade IIIb
0.004 0.996 0.000
N42.9 Disorder of prostate, unspecified
0.000 0.997 0.003
C85.1 B-cell lymphoma, unspecified
0.003 0.997 0.000
S68 Traumatic amputation of wrist and hand
0.000 0.997 0.003
C82.1 Mixed small cleaved and large cell, follicular
0.003 0.997 0.000
C82.2 Large cell, follicular
0.003 0.997 0.000
C84.5 Other and unspecified T-cell lymphomas
0.003 0.997 0.000
N42 Other disorders of prostate
0.000 0.997 0.003
Z98.2 Presence of cerebrospinal fluid drainage device
0.000 0.997 0.003
C82.0 Small cleaved cell, follicular
0.003 0.997 0.000
Y86 Sequelae of other accidents
0.003 0.997 0.000
D04.7 Skin of lower limb, including hip
0.003 0.997 0.000
Z98.1 Arthrodesis status
0.000 0.997 0.003
L03.9 Cellulitis, unspecified
0.003 0.997 0.000
M41.99 Scoliosis, unspecified (Site unspecified)
0.003 0.997 0.000
E04.1 Non-toxic single thyroid nodule
0.000 0.997 0.003
F31.9 Bipolar affective disorder, unspecified
0.003 0.997 0.000
D04.4 Skin of scalp and neck
0.003 0.997 0.000
C90 Multiple myeloma and malignant plasma cell neoplasms
0.003 0.997 0.000
D33.3 Cranial nerves
0.003 0.997 0.000
N60.3 Fibrosclerosis of breast
0.000 0.997 0.003
O72.1 Other immediate postpartum haemorrhage
0.000 0.997 0.003
D51.0 Vitamin B12 deficiency anaemia due to intrinsic factor deficiency
0.000 0.997 0.003
R01.1 Cardiac murmur, unspecified
0.003 0.997 0.000
D04 Carcinoma in situ of skin
0.003 0.997 0.000
S68.9 Traumatic amputation of wrist and hand, level unspecified
0.000 0.997 0.003
S68.8 Traumatic amputation of other parts of wrist and hand
0.000 0.997 0.003
S68.4 Traumatic amputation of hand at wrist level
0.000 0.997 0.003
S68.3 Combined traumatic amputation of (part of) finger(s) with other parts of wrist and hand
0.000 0.997 0.003
D04.6 Skin of upper limb, including shoulder
0.003 0.997 0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.003 0.997 0.000
H06.2 Dysthyroid exophthalmos
0.003 0.997 0.000
Z60.2 Living alone
0.003 0.997 0.000
D04.9 Skin, unspecified
0.002 0.997 0.000
H65.0 Acute serous otitis media
0.000 0.997 0.002
N42.3 Dysplasia of prostate
0.000 0.997 0.002
M41.9 Scoliosis, unspecified
0.003 0.997 0.000
M41.95 Scoliosis, unspecified (Thoracolumbar region)
0.002 0.998 0.000
I85.9 Oesophageal varices without bleeding
0.002 0.998 0.000
M31.6 Other giant cell arteritis
0.002 0.998 0.000
S20.8 Superficial injuries of other and unspecified parts of thorax
0.000 0.998 0.002
C90.3 Solitary plasmacytoma
0.002 0.998 0.000
D04.2 Skin of ear and external auricular canal
0.002 0.998 0.000
S68.0 Traumatic amputation of thumb (complete)(partial)
0.000 0.998 0.002
M41.90 Scoliosis, unspecified (Multiple sites in spine)
0.002 0.998 0.000
M41.97 Scoliosis, unspecified (Lumbosacral region)
0.002 0.998 0.000
M84.48 Pathological fracture, not elsewhere classified (Other)
0.002 0.998 0.000
G44.2 Tension-type headache
0.000 0.998 0.002
D04.8 Skin of other sites
0.002 0.998 0.000
D04.0 Skin of lip
0.002 0.998 0.000
M17.3 Other posttraumatic gonarthrosis
0.002 0.998 0.000
S20.3 Other superficial injuries of front wall of thorax
0.000 0.998 0.002
D89 Other disorders involving the immune mechanism, not elsewhere classified
0.002 0.998 0.000
H65 Nonsuppurative otitis media
0.000 0.998 0.002
D04.1 Skin of eyelid, including canthus
0.002 0.998 0.000
M51.9 Intervertebral disk disorder, unspecified
0.002 0.998 0.000
Q66.8 Other congenital deformities of feet
0.002 0.998 0.000
M51 Other intervertebral disk disorders
0.002 0.998 0.000
D04.5 Skin of trunk
0.002 0.998 0.000
M41.94 Scoliosis, unspecified (Thoracic region)
0.002 0.998 0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.002 0.998 0.000
J13 Pneumonia due to Streptococcus pneumoniae
0.002 0.998 0.000
D89.0 Polyclonal hypergammaglobulinaemia
0.002 0.998 0.000
H65.4 Other chronic nonsuppurative otitis media
0.000 0.998 0.002
N42.8 Other specified disorders of prostate
0.000 0.998 0.002
S68.2 Traumatic amputation of two or more fingers alone (complete)(partial)
0.000 0.998 0.002
M41.98 Scoliosis, unspecified (Sacral and sacrococcygeal region)
0.002 0.998 0.000
M41.93 Scoliosis, unspecified (Cervicothoracic region)
0.002 0.998 0.000
M41.92 Scoliosis, unspecified (Cervical region)
0.002 0.998 0.000
M41.91 Scoliosis, unspecified (Occipito-atlanto-axial region)
0.002 0.998 0.000
N42.2 Atrophy of prostate
0.000 0.998 0.002
D75.8 Other specified diseases of blood and blood-forming organs
0.002 0.998 0.000
X78.0 Home
0.000 0.998 0.002
C90.1 Plasma cell leukaemia
0.002 0.998 0.000
N42.0 Calculus of prostate
0.000 0.998 0.002
Z48.9 Surgical follow-up care, unspecified
0.002 0.998 0.000
X65.8 Other specified place
0.002 0.998 0.000
Q66.2 Metatarsus varus
0.002 0.998 0.000
S20 Superficial injury of thorax
0.000 0.998 0.002
M88.90 Paget's disease of bone, unspecified (Multiple sites)
0.002 0.998 0.000
F10.4 Withdrawal state with delirium
0.000 0.998 0.002
H65.9 Nonsuppurative otitis media, unspecified
0.000 0.998 0.002
M51.8 Other specified intervertebral disk disorders
0.002 0.998 0.000
N87.1 Moderate cervical dysplasia
0.000 0.998 0.002
T18.1 Foreign body in oesophagus
0.000 0.998 0.002
D89.9 Disorder involving the immune mechanism, unspecified
0.002 0.998 0.000
M84.12 Nonunion of fracture [pseudarthrosis] (Upper arm)
0.002 0.998 0.000
D89.3 Immune reconstitution syndrome
0.002 0.998 0.000
M51.1 Lumbar and other intervertebral disk disorders with radiculopathy
0.002 0.998 0.000
M51.4 Schmorl's nodes
0.002 0.998 0.000
S20.2 Contusion of thorax
0.000 0.998 0.002
M84.11 Nonunion of fracture [pseudarthrosis] (Shoulder region)
0.002 0.998 0.000
W22.9 Unspecified place
0.000 0.998 0.002
Q66 Congenital deformities of feet
0.002 0.998 0.000
X60.2 School, other institution and public administrative area
0.002 0.998 0.000
H27.1 Dislocation of lens
0.000 0.998 0.002
X60 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics
0.002 0.998 0.000
M84.15 Nonunion of fracture [pseudarthrosis] (Pelvic region and thigh)
0.002 0.998 0.000
D04.3 Skin of other and unspecified parts of face
0.002 0.998 0.000
X65 Intentional self-poisoning by and exposure to alcohol
0.002 0.998 0.000
D89.8 Other specified disorders involving the immune mechanism, not elsewhere classified
0.002 0.998 0.000
M51.3 Other specified intervertebral disk degeneration
0.002 0.998 0.000
V44.5 Driver injured in traffic accident
0.002 0.998 0.000
M88.95 Paget's disease of bone, unspecified (Pelvic region and thigh)
0.002 0.998 0.000
L05.9 Pilonidal cyst without abscess
0.000 0.998 0.002
O81.4 Vacuum extractor delivery
0.002 0.998 0.000
X60.8 Other specified place
0.002 0.998 0.000
M84.4 Pathological fracture, not elsewhere classified
0.002 0.998 0.000
Q66.0 Talipes equinovarus
0.002 0.998 0.000
D33.2 Brain, unspecified
0.002 0.998 0.000
Y88.1 Sequelae of misadventures to patients during surgical and medical procedures
0.002 0.998 0.000
M41 Scoliosis
0.002 0.998 0.000
Y88 Sequelae of surgical and medical care as external cause
0.002 0.998 0.000
Y88.3 Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient or of later complication, without mention of misadventure at the time of the procedure
0.002 0.998 0.000
H65.1 Other acute nonsuppurative otitis media
0.000 0.998 0.002
X69.0 Home
0.002 0.998 0.000
D89.1 Cryoglobulinaemia
0.001 0.998 0.000
H81.2 Vestibular neuronitis
0.002 0.998 0.000
Q66.9 Congenital deformity of feet, unspecified
0.002 0.998 0.000
S20.7 Multiple superficial injuries of thorax
0.000 0.998 0.002
M84.87 Other disorders of continuity of bone (Ankle and foot)
0.002 0.998 0.000
H27.0 Aphakia
0.000 0.998 0.002
M84.1 Nonunion of fracture [pseudarthrosis]
0.002 0.998 0.000
S20.1 Other and unspecified superficial injuries of breast
0.000 0.998 0.002
T84.7 Infection and inflammatory reaction due to other internal orthopaedic prosthetic devices, implants and grafts
0.000 0.998 0.002
X78 Intentional self-harm by sharp object
0.001 0.998 0.001
M23.39 Other meniscus derangements (Unspecified ligament or Unspecified meniscus)
0.000 0.998 0.002
D33 Benign neoplasm of brain and other parts of central nervous system
0.002 0.998 0.000
X60-X84 Intentional self-harm
0.002 0.998 0.000
M51.19 Lumbar and other intervertebral disc disorders with radiculopathy; site unspecified
0.001 0.998 0.000
M51.16 Intervertebral disc disorders w radiculopathy, lumbar region
0.001 0.998 0.000
X69 Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
0.002 0.998 0.000
C90.2 Plasmacytoma, extramedullary
0.001 0.998 0.000
M41.4 Neuromuscular scoliosis
0.001 0.998 0.000
Q66.6 Other congenital valgus deformities of feet
0.001 0.998 0.000
Q66.5 Congenital pes planus
0.001 0.998 0.000
Q66.4 Talipes calcaneovalgus
0.001 0.998 0.000
Q66.1 Talipes calcaneovarus
0.001 0.998 0.000
S20.0 Contusion of breast
0.000 0.998 0.001
M84.42 Pathological fracture, not elsewhere classified (Upper arm)
0.001 0.998 0.000
M88.9 Paget's disease of bone, unspecified
0.002 0.998 0.000
Y88.0 Sequelae of adverse effects caused by drugs, medicaments and biological substances in therapeutic use
0.001 0.998 0.000
X62 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified
0.002 0.998 0.000
X61 Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified
0.001 0.998 0.000
M06.93 Rheumatoid arthritis, unspecified (Forearm)
0.000 0.998 0.002
X60.9 Unspecified place
0.001 0.998 0.000
X60.0 Home
0.001 0.998 0.000
X60.7 Farm
0.001 0.998 0.000
X60.6 Industrial and construction area
0.001 0.998 0.000
X60.5 Trade and service area
0.001 0.998 0.000
X60.4 Street and highway
0.001 0.998 0.000
X60.3 Sports and athletics area
0.001 0.998 0.000
X60.1 Residential institution
0.001 0.998 0.000
X61.2 School, other institution and public administrative area
0.001 0.998 0.000
M41.8 Other forms of scoliosis
0.001 0.998 0.000
X65.9 Unspecified place
0.001 0.998 0.000
X65.0 Home
0.001 0.998 0.000
X65.7 Farm
0.001 0.998 0.000
X65.6 Industrial and construction area
0.001 0.998 0.000
X65.5 Trade and service area
0.001 0.998 0.000
X65.4 Street and highway
0.001 0.998 0.000
X65.3 Sports and athletics area
0.001 0.998 0.000
X65.2 School, other institution and public administrative area
0.001 0.998 0.000
X65.1 Residential institution
0.001 0.998 0.000
X83 Intentional self-harm by other specified means
0.001 0.998 0.000
X62.9 Unspecified place
0.002 0.998 0.000
M06.96 Rheumatoid arthritis, unspecified (Lower leg)
0.000 0.998 0.002
M41.49 Neuromuscular scoliosis (Site unspecified)
0.001 0.998 0.000
M84.49 Pathological fracture, not elsewhere classified (Site unspecified)
0.001 0.998 0.000
M84.47 Pathological fracture, not elsewhere classified (Ankle and foot)
0.001 0.998 0.000
M84.46 Pathological fracture, not elsewhere classified (Lower leg)
0.001 0.998 0.000
M84.44 Pathological fracture, not elsewhere classified (Hand)
0.001 0.998 0.000
M84.43 Pathological fracture, not elsewhere classified (Forearm)
0.001 0.998 0.000
M84.41 Pathological fracture, not elsewhere classified (Shoulder region)
0.001 0.998 0.000
M84.40 Pathological fracture, not elsewhere classified (Multiple sites)
0.001 0.998 0.000
M84.8 Other disorders of continuity of bone
0.001 0.998 0.000
X83.9 Unspecified place
0.001 0.998 0.000
M84.14 Nonunion of fracture [pseudarthrosis] (Hand)
0.001 0.998 0.000
S52.10 Fracture of upper end of radius (closed)
0.000 0.998 0.002
D37.4 Colon
0.000 0.998 0.002
J04.0 Acute laryngitis
0.000 0.998 0.001
M41.5 Other secondary scoliosis
0.001 0.998 0.000
M41.3 Thoracogenic scoliosis
0.001 0.998 0.000
M41.2 Other idiopathic scoliosis
0.001 0.998 0.000
M41.1 Juvenile idiopathic scoliosis
0.001 0.998 0.000
M41.0 Infantile idiopathic scoliosis
0.001 0.998 0.000
Q79.6 Ehlers-Danlos syndrome
0.001 0.998 0.000
S20.4 Other superficial injuries of back wall of thorax
0.000 0.998 0.001
Y88.2 Sequelae of adverse incidents associated with medical devices in diagnostic and therapeutic use
0.001 0.998 0.000
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms
0.001 0.998 0.000
K31.8 Other specified diseases of stomach and duodenum
0.000 0.998 0.002
V59.8 Occupant [any] of pick-up truck or van injured in other specified transport accidents
0.001 0.998 0.000
X84 Intentional self-harm by unspecified means
0.001 0.998 0.000
M05.90 Seropositive rheumatoid arthritis, unspecified (Multiple sites)
0.000 0.999 0.001
V01.1 Traffic accident
0.001 0.999 0.000
M23.35 Other meniscus derangements (Posterior horn of lateral meniscus)
0.000 0.999 0.001
M84.19 Nonunion of fracture [pseudarthrosis] (Site unspecified)
0.001 0.999 0.000
M84.10 Nonunion of fracture [pseudarthrosis] (Multiple sites)
0.001 0.999 0.000
D33.0 Brain, supratentorial
0.001 0.999 0.000
Q66.7 Pes cavus
0.001 0.999 0.000
V10.4 Driver injured in traffic accident
0.001 0.999 0.000
X59.3 Sports and athletics area
0.001 0.999 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2025 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.